A detailed history of Nexus Investment Management Ulc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nexus Investment Management Ulc holds 23,300 shares of BHC stock, worth $190,827. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,300
Previous 23,300 -0.0%
Holding current value
$190,827
Previous $162,000 16.67%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 04, 2023

SELL
$6.28 - $9.85 $6,280 - $9,850
-1,000 Reduced 4.12%
23,300 $188,000
Q1 2021

Apr 09, 2021

SELL
$21.37 - $34.38 $81,206 - $130,644
-3,800 Reduced 13.52%
24,300 $771,000
Q4 2019

Jan 06, 2020

SELL
$18.89 - $31.89 $94,450 - $159,450
-5,000 Reduced 15.11%
28,100 $842,000
Q4 2018

Jan 14, 2019

SELL
$17.64 - $28.32 $8,820 - $14,160
-500 Reduced 1.49%
33,100 $612,000
Q3 2018

Oct 10, 2018

BUY
$20.64 - $25.67 $693,504 - $862,512
33,600 New
33,600 $862,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.96B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Nexus Investment Management Ulc Portfolio

Follow Nexus Investment Management Ulc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nexus Investment Management Ulc, based on Form 13F filings with the SEC.

News

Stay updated on Nexus Investment Management Ulc with notifications on news.